JG
CNTA

Jain Global’s Centessa Pharmaceuticals CNTA Stock Holding History

Jain Global’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Sell
71,513
-844,290
-92% -$21.6M 0.01% 606
2025
Q4 		$22.9M Buy
915,803
+673,828
+278% +$17.1M 0.11% 191
2025
Q3 		$5.87M Buy
+241,975
New +$4.3M 0.03% 324
2025
Q1 		– Sell
-23,466
Closed -$393K – 1117
2024
Q4 		$393K Buy
+23,466
New +$389K 0.01% 505

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Jain Global's CNTA Position: Q1 2026 in Review

Jain Global reduced its Centessa Pharmaceuticals (CNTA) stake by 92% in Q1 2026, selling an estimated $21.6M and leaving 71,513 shares worth $2.84M. The position accounts for 0.01% of the portfolio, ranked #606.

Jain Global first reported a position in CNTA in Q4 2024 and has held it in 4 quarters since. The position peaked at $22.9M in Q4 2025. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Jain Global held 71,513 shares of Centessa Pharmaceuticals worth $2.84M as of Q1 2026.
  • Jain Global sold 844,290 Centessa Pharmaceuticals shares in Q1 2026, an estimated $21.6M.
  • Centessa Pharmaceuticals made up 0.01% of Jain Global's portfolio in Q1 2026, its #606 holding.
  • Jain Global first reported a position in Centessa Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • Jain Global's Centessa Pharmaceuticals position peaked at $22.9M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.